These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

183 related items for PubMed ID: 359269

  • 21. [Research regarding extended-spectrum beta-lactamases produced by enterobacteria strains].
    Copăcianu B, Tuchiluş C, Poiata A, Iancu LS.
    Rev Med Chir Soc Med Nat Iasi; 2010; 114(3):896-9. PubMed ID: 21243821
    [Abstract] [Full Text] [Related]

  • 22. [Cefotaxime, syn isomer of a new methoxyimino cephalosporin with unusual activity (author's transl)].
    Chabbert YA, Lutz A.
    Nouv Presse Med; 1981 Feb 26; 10(8):541-4. PubMed ID: 6259588
    [Abstract] [Full Text] [Related]

  • 23. Ceftibuten and bactericidal kinetics. Comparative in vitro activity against Enterobacteriaceae producing extended spectrum beta-lactamases.
    Bauernfeind A.
    Diagn Microbiol Infect Dis; 1991 Feb 26; 14(1):89-92. PubMed ID: 2013215
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. A comparison of cefamandole, cefoxitin, cefuroxime, cefotaxime and cefoperazone: an in vitro test on a number of beta-lactamase producing strains of 9 species and 1 genus of bacteria.
    Kuipers JS.
    Curr Med Res Opin; 1981 Feb 26; 7(3):196-203. PubMed ID: 6971210
    [Abstract] [Full Text] [Related]

  • 28. Ecological impact of ampicillin and cefuroxime in neonatal units.
    Tullus K, Burman LG.
    Lancet; 1989 Jun 24; 1(8652):1405-7. PubMed ID: 2567427
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. In vitro activity of tigecycline against clinical isolates of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae, Serratia marcescens and Enterobacter cloacae.
    Ku YH, Chuang YC, Yu WL.
    J Microbiol Immunol Infect; 2008 Aug 24; 41(4):332-6. PubMed ID: 18787741
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Antibacterial activity of cefuroxime, a new cephalosporin antibiotic, compared with that of cephaloridine, cephalothin, and cefamandole.
    Eykyn S, Jenkins C, King A, Phillips I.
    Antimicrob Agents Chemother; 1976 Apr 24; 9(4):690-5. PubMed ID: 1267441
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. In vitro activity of avibactam (NXL104) in combination with β-lactams against Gram-negative bacteria, including OXA-48 β-lactamase-producing Klebsiella pneumoniae.
    Aktaş Z, Kayacan C, Oncul O.
    Int J Antimicrob Agents; 2012 Jan 24; 39(1):86-9. PubMed ID: 22041508
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Control of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a children's hospital by changing antimicrobial agent usage policy.
    Lee J, Pai H, Kim YK, Kim NH, Eun BW, Kang HJ, Park KH, Choi EH, Shin HY, Kim EC, Lee HJ, Ahn HS.
    J Antimicrob Chemother; 2007 Sep 24; 60(3):629-37. PubMed ID: 17599919
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.